Post by
Joemare on Dec 02, 2022 10:39am
Heads need to role
ASAP.
Always a bad sign when biotech is mute on clinical trial updates, especially during a call. They new back in October. The trend was there. Lack of competency.
Comment by
Joemare on Dec 02, 2022 10:48am
And clarity on NASH is required asap as well. No more wishy washy comments. Clear path to success for NASH or the big guy should exit.